Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Endocr J. 2022 Jun 28;69(6):605-612. doi: 10.1507/endocrj.EJ22-0083. Epub 2022 Apr 26.
Glucose is not only the energy fuel for most cells, but also the signaling molecule which affects gene expression via carbohydrate response element binding protein (ChREBP), a Mondo family transcription factor. In response to high glucose conditions, ChREBP regulates glycolytic and lipogenic genes by binding to carbohydrate response elements (ChoRE) in the regulatory region of its target genes, thus elucidating the role of ChREBP for converting excessively ingested carbohydrates to fatty acids as an energy storage in lipogenic tissues such as the liver and adipose tissue. While the pathophysiological roles of ChREBP for fatty liver and obesity in these tissues are well known, much of the physiological and pathophysiological roles of ChREBP in other tissues such as the kidney remains unclear despite its high levels of expression in them. This review will thus highlight the roles of ChREBP in the kidney and briefly introduce the latest research results that have been reported so far.
葡萄糖不仅是大多数细胞的能量燃料,还是一种信号分子,通过碳水化合物反应元件结合蛋白(ChREBP)影响基因表达,ChREBP 是一个 Mondo 家族转录因子。在高葡萄糖条件下,ChREBP 通过与靶基因调控区的碳水化合物反应元件(ChoRE)结合,调节糖酵解和脂肪生成基因,从而阐明 ChREBP 将过量摄入的碳水化合物转化为脂肪酸的作用,作为肝脏和脂肪组织等脂肪生成组织的能量储存。虽然 ChREBP 在这些组织中导致脂肪肝和肥胖的病理生理作用已广为人知,但尽管 ChREBP 在肾脏等其他组织中高表达,其在这些组织中的许多生理和病理生理作用仍不清楚。因此,本文将重点介绍 ChREBP 在肾脏中的作用,并简要介绍迄今为止已报道的最新研究结果。